Accuracy of plasma levels of polymorphonuclear elastase as early prognostic marker of acute pancreatitis in routine clinical conditions

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 1, 2006, Pages 79-83

  Domínguez Muñoz, J Enrique ^a   Villanueva, Augusto ^a   Lariño, José ^a   Mora, Teresa ^a   Barreiro, Manuel ^a   Iglesias Canle, José ^a   Iglesias García, Julio ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Acute pancreatitis; Polymorphonuclear elastase; Prognostic evaluation; Severity

Indexed keywords

ELASTASE;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMICAL ANALYSIS; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STUDENT T TEST;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PANCREATIC ELASTASE; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 29344454482     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200601000-00014     Document Type: Article

References (42)

1. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139:69-81.
2. Lankisch PG, Schirren CA, Otto J. Methemalbumin in acute pancreatitis: an evaluation of its prognostic value and comparison with multiple prognostic parameters. Am J Gastroenterol 1989; 84:1391-1395.
3. Warshaw AL, Lee KH. Serum ribonuclease elevations and pancreatic necrosis in acute pancreatitis. Surgery 1979; 86:227-234.
4. Hedstrom J, Kemppainen E, Andersen J, Jokela H, Puolakkainen P, Stenman UH. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis. Am J Gastroenterol 2001; 96:424-430.
5. Dominguez-Munoz JE, Carballo F, Garcia MJ, Miguel de Diego J, Gea F, Yanguela J, et al. Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis. Results of a prospective multicenter study. Dig Dis Sci 1993; 38:507-513.
6. Lankisch PG, Koop H, Kaboth U. Serum complement factors in human acute pancreatitis. Hepatogastroenterology 1981; 28:261-263.
7. Aufenanger J, Samman M, Quintel M, Fassbender K, Zimmer W, Bertsch T. Pancreatic phospholipase A2 activity in acute pancreatitis: a prognostic marker for early identification of patients at risk. Clin Chem Lab Med 2002; 40:293-297.
8. Puolakkainen P, Valtonen V, Paananen A, Schroder T. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987; 28:764-771.
9. Ranson JH, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 1976; 143:209-219.
10. Blarney SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut 1984; 25:1340-1346.
11. Dominguez-Munoz JE, Carballo F, Garcia MJ, de Diego JM, Campos R, Yanguela J, et al. Evaluation of the clinical usefulness of APACHE II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicentre study. Pancreas 1993; 8:682-686.
12. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; ii:201-205.
13. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77:1260-1264.
14. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355:1955-1960.
15. Lempinen M, Stenman UH, Finne P, Puolakkainen P, Haapiainen R, Kemppainen E. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. J Surg Res 2003; 111:267-273.
16. Appelros S, Petersson U, Toh S, Johnson C, Borgstrom A. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001; 88:216-221.
17. Muller CA, Appelros S, Uhl W, Buchler MW, Borgstrom A. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002; 51:229-235.
18. Lempinen M, Kylanpaa-Back ML, Stenman UH, Puolakkainen P, Haapiainen R, Finne P, et al. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin Chem 2001; 47:2103-2107.
19. Bathia M, Brady M, Shokuchi S, Christmas S, Neoptolemos J, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol 2000; 190:117-125.
20. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobil Pancreat Surg 2002; 9:401-410.
21. Weber CK, Adler G. From acinar cell damage to systemic inflammatory response: current concepts in pancreatitis. Pancreatology 2001; 1:356-362.
22. Dominguez-Munoz JE, Viedma JA, Perez-Mateo M, Carballo F, Garcia Fe M. Inflammatory response in the initial phase of acute pancreatitis: relationship to the onset and severity of the disease. Rev Esp Enferm Dig 1995; 87:225-246.
23. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47:546-552.
24. Mora A, Pèrez-Mateo M, Viedma JA, Carballo F, Sanchez-Paya J, Liras G. Activation of cellular immune response in acute pancreatitis. Gut 1997; 40:794-797.
25. Viedma JA, Pérez-Mateo M, Agullo J, Domínguez JE, Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994; 35:822-827.
26. Büchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis: results of a prospective study. Int J Pancreatol 1986; 37:227-235.
27. Mayer AD, McMahon MJ, Bowen M, Cooper EH. C-reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol 1984; 37:207-211.
28. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76:177-181.
29. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992; 33:1126-1128.
30. Liras G, Carballo F, Dominguez-Munoz E, De la Morena J. Clinical value of an automated granulocyte elastase assay in predicting severity of acute pancreatitis. Rev Esp Enferm Dig 1995; 87:641-652.
31. Dominguez-Munoz JE, Carballo F, Garcia MJ, de Diego JM, Rabago L, Simon MA, et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg 1991; 78:1230-1234.
32. Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6:253-259.
33. Gross V, Scholmerich J, Leser HG, Salm R, Lausen M, Ruckauer K, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci 1990; 35:97-105.
34. Viedma JA, Pérez-Mateo M, Domínguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33:1264-1267.
35. Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelletti O, Morselli-Labate AM, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with C-reactive protein. Dig Dis Sci 1995; 40:2341-2348.
36. Chen CC, Wang SS, Lu RH, Chang FY, Lee SD. Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis. Gut 1999; 45:895-899.
37. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41:832-840.
38. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34:41-45.
39. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101:782-785.
40. Bradley EL III. A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128:586-590.
41. Domínguez-Muñoz JE. Treatment of acute pancreatitis in clinical practice: a global view. In: Domínguez-Muñoz JE, editor. Clinical pancreatology for practising gastroenterologists and surgeons. Oxford: Blackwell Publishing Ltd; 2005. pp. 176-179.
42. Hafner G, Erbes H, Drosdat H, Lotz J, Ehrental W, Wuerzburg U. Evaluation of a new assay for the determination of PMN-elastase-α1-proteinase inhibitor complexes in EDTA and citrated plasma. Clin Lab 1997; 43:3-9.